Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2504049 | International Journal of Pharmaceutics | 2010 | 5 Pages |
Abstract
A novel synthetic nanocomplex was constructed from glycol chitosan (GCS) grafted with 2,3-dimethylmaleic anhydride (DMA) (denoted as ‘GCD’ hereafter) and lysozyme (isoelectric point = 10.9) as a model protein. This is a core-shell supramolecular assemble formed through electrostatic interactions between anionic GCD and cationic lysozyme at a pH 7.4. The pH-sensitivity of the nanocomplexes originates from the dissociation of DMA block from GCD at a slightly acidic pH (i.e., pH 6.8), resulting in an increased electrostatic repulsion between cationic GCS and cationic lysozyme. This pH-induced charge switching of GCD provides a mechanism for triggered protein drug release from the nanocomplexes triggered by the small change in pH (pH 7.4–6.8).
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
Bo Reum Lee, Kyung Taek Oh, Hye Jung Baik, Yu Seok Youn, Eun Seong Lee,